- Home
- WEX vs TECH Comparison
WEX vs TECH Comparison
Compare WEX & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WEX
- TECH
- Stock Information
- Founded
- WEX 1983
- TECH 1976
- Country
- WEX United States
- TECH United States
- Employees
- WEX N/A
- TECH N/A
- Industry
- WEX Business Services
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WEX Consumer Discretionary
- TECH Health Care
- Exchange
- WEX Nasdaq
- TECH Nasdaq
- Market Cap
- WEX N/A
- TECH 7.9B
- IPO Year
- WEX 2005
- TECH 1989
- Fundamental
- Price
- WEX $126.72
- TECH $49.78
- Analyst Decision
- WEX Buy
- TECH Buy
- Analyst Count
- WEX 12
- TECH 9
- Target Price
- WEX $186.80
- TECH $73.88
- AVG Volume (30 Days)
- WEX 599.9K
- TECH 2.1M
- Earning Date
- WEX 04-30-2025
- TECH 05-07-2025
- Dividend Yield
- WEX N/A
- TECH 0.64%
- EPS Growth
- WEX 26.46
- TECH N/A
- EPS
- WEX 7.78
- TECH 0.83
- Revenue
- WEX $2,612,100,000.00
- TECH $1,208,770,000.00
- Revenue This Year
- WEX $0.83
- TECH $8.19
- Revenue Next Year
- WEX $5.40
- TECH $8.61
- P/E Ratio
- WEX $16.24
- TECH $59.98
- Revenue Growth
- WEX 0.90
- TECH 4.72
- 52 Week Low
- WEX $110.45
- TECH $46.44
- 52 Week High
- WEX $217.47
- TECH $85.57
- Technical
- Relative Strength Index (RSI)
- WEX 45.52
- TECH 43.61
- Support Level
- WEX $120.03
- TECH $46.77
- Resistance Level
- WEX $126.33
- TECH $51.54
- Average True Range (ATR)
- WEX 4.52
- TECH 2.08
- MACD
- WEX 0.78
- TECH 0.36
- Stochastic Oscillator
- WEX 51.37
- TECH 50.07
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.